GPC2-CAR T Cells Tuned for Low Antigen Density Mediate Potent Activity against Neuroblastoma without Toxicity

Scientists developed T cells expressing CARs targeting glypican-2 (GPC2), a fetal antigen expressed on neuroblastoma and several other solid tumors.